LIZABETH SPINK: Open Payments
NPI 1902299373 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 17 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $27 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $169 |
| Novo Nordisk Inc | 5 | $100 |
| Amgen Inc. | 2 | $46 |
| PFIZER INC. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $22 |
Products named: ZEPBOUND, MOUNJARO, Ozempic, OTEZLA, Wegovy, JARDIANCE, APTIMA, Kerendia.
Industry payments across CA — which companies pay providers there.
